Endometrial cancer: not a benign disease.
Endometrial cancer is by no means a benign disease. While many adequate treatment plans now exist for early endometrial cancer, the best method of treadtment of this disease has yet to be defined. The prognostic factors need further study and definition. Pelvic and aortic nodes are of more than passing significance in certain subsets of Stage 1 endometrial cancer, and there is much to be learned about the biologic behavior of apparent early endometrial cancer. Prospective studies may yield sufficient data to provide a solid base for further clinical therapeutic trials.
D000230:Adenocarcinoma / Q000473:pathology* / Q000601:surgery; D004717:Endometrium / Q000473:pathology*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D008198:Lymph Nodes / Q000473:pathology; D009215:Myometrium / Q000473:pathology; D009362:Neoplasm Metastasis; D010385:Pelvic Exenteration; D011379:Prognosis; D014594:Uterine Neoplasms / Q000145:classification / Q000401:mortality / Q000473:pathology* / Q000532:radiotherapy / Q000601:surgery